U.S. sales of morning-after pill double

July 13, 2007

Sales of the morning-after pill Plan B in the United States have doubled since it was made available without a prescription.

Drug maker Barr Pharmaceuticals said sales will probably be close to $80 million for 2007, The Washington Post said Friday.

The Food and Drug Administration approved the sale of the controversial emergency contraceptive without a prescription for women 18 and older last August.

Women's health and family-planning advocates say it illustrates the value of easing access to birth control to help prevent unwanted pregnancies, the newspaper said.

Conservative groups, however, question the drug's safety and maintain the pill can cause the equivalent of an abortion.

Advocates would like to see the FDA remove the age restriction.

Copyright 2007 by United Press International

Explore further: FDA to review first of 3 new weight loss drugs

Related Stories

FDA to review first of 3 new weight loss drugs

July 12, 2010

(AP) -- Dieters, doctors and investors get their first extensive look at the first of a trio of new weight loss drugs this week. The hope is that the new drugs can succeed where many others have failed: delivering significant ...

Watchdog group makes 2nd push to ban diet pill

April 18, 2011

(AP) -- For the second time in five years, public health advocates are calling on the Food and Drug Administration to ban a fat-blocking drug sold over-the counter and via prescription, pointing to new reports of kidney ...

Drugs seeping into Lake Michigan

April 15, 2007

Drugs are seeping into the Grand River and Lake Michigan from the Grand Rapids, Mich., sewage treatment plant, a study found.

US aims at its deadliest drug problem: painkillers

April 20, 2011

(AP) -- The White House drug czar wants doctors, states and law enforcement working harder to stop America's deadliest drug-abuse problem: highly addictive prescription painkillers. They are killing more people than heroin ...

Study raises new questions about Merck pill Zetia

November 16, 2009

(AP) -- A new study raises fresh concerns about Zetia and its cousin, Vytorin - drugs still taken by millions of Americans to lower cholesterol, despite questions raised last year about how well they work.

Recommended for you

How the finch changes its tune

August 3, 2015

Like top musicians, songbirds train from a young age to weed out errors and trim variability from their songs, ultimately becoming consistent and reliable performers. But as with human musicians, even the best are not machines. ...

Machine Translates Thoughts into Speech in Real Time

December 21, 2009

(PhysOrg.com) -- By implanting an electrode into the brain of a person with locked-in syndrome, scientists have demonstrated how to wirelessly transmit neural signals to a speech synthesizer. The "thought-to-speech" process ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.